Search research articles
Contact Us
Filters
Showing results (171-180 of 390) with videos related to
Page
of 39
Sort By:
The Lancet. Neurology
|
February 24, 2017
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid, Laura Balcer, Steven Galetta, et al.
Clinical Epigenetics
|
February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Plos One
|
May 26, 2011
Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice
Ellen Menkhorst, Jian-Guo Zhang, Natalie A Sims, et al.
Multiple Sclerosis and Related Disorders
|
March 17, 2023
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis
Lana Zhovtis Ryerson, John F Foley, Gilles Defer, et al.
JMIR Research Protocols
|
October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 1, 2025
Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis
Daniel Merlo, Johnson Ja, Yi Chao Foong, et al.
Scientific Reports
|
January 3, 2024
Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study
Jiwon Oh, Luca Capezzuto, Lito Kriara, et al.
Immunogenetics
|
January 27, 2007
Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients
Justin P Rubio, Melanie Bahlo, Jim Stankovich, et al.
Therapeutic Advances in Neurological Disorders
|
March 25, 2024
Comparative efficacy of ofatumumab <i>versus</i> oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons
Nicholas Riley, Christopher Drudge, Morag Nelson, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 15, 2024
Language impairments in seropositive and seronegative autoimmune encephalitis
Sarah P Griffith, Robb Wesselingh, Fiore D'Aprano, et al.
Page
of 39
Search research articles
Search
Showing results (171-180 of 390) with videos related to
Sort By:
Page
of 39
The Lancet. Neurology
|
February 24, 2017
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
Diego Cadavid, Laura Balcer, Steven Galetta, et al.
Clinical Epigenetics
|
February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis
Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.
Plos One
|
May 26, 2011
Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice
Ellen Menkhorst, Jian-Guo Zhang, Natalie A Sims, et al.
Multiple Sclerosis and Related Disorders
|
March 17, 2023
Exploratory clinical efficacy and patient-reported outcomes from NOVA: A randomized controlled study of intravenous natalizumab 6-week dosing versus continued 4-week dosing for relapsing-remitting multiple sclerosis
Lana Zhovtis Ryerson, John F Foley, Gilles Defer, et al.
JMIR Research Protocols
|
October 19, 2021
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
Vicki E Maltby, Rodney A Lea, Mastura Monif, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 1, 2025
Long-term acceptability of MSReactor digital cognitive monitoring among people living with multiple sclerosis
Daniel Merlo, Johnson Ja, Yi Chao Foong, et al.
Scientific Reports
|
January 3, 2024
Use of smartphone-based remote assessments of multiple sclerosis in Floodlight Open, a global, prospective, open-access study
Jiwon Oh, Luca Capezzuto, Lito Kriara, et al.
Immunogenetics
|
January 27, 2007
Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients
Justin P Rubio, Melanie Bahlo, Jim Stankovich, et al.
Therapeutic Advances in Neurological Disorders
|
March 25, 2024
Comparative efficacy of ofatumumab <i>versus</i> oral therapies for relapsing multiple sclerosis patients using propensity score analyses and simulated treatment comparisons
Nicholas Riley, Christopher Drudge, Morag Nelson, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 15, 2024
Language impairments in seropositive and seronegative autoimmune encephalitis
Sarah P Griffith, Robb Wesselingh, Fiore D'Aprano, et al.
Page
of 39